Abstract:Editorial Office Gland Surgery Submitted Apr 28, 2024. Accepted for publication Jul 18, 2024. Published online Aug 28, 2024. doi: 10.21037/gs-2024-1 Erratum to: Gland Surg 2023;12:1326-7 In the June 2023 issue of Gland Surgery , the paper titled "Erratum to relationships between serum levels of vitamins and papillary thyroid cancer: a single center case-control study" ( Gland Surg 2023;12:1326-7. doi: 10.21037/gs-2023-04) (1), was published for correction of the registration number of the ethics board in the article (2) published earlier. However, there are still some errors found in the funding information. The updated "Acknowledgments" section and "Footnote" section are presented below. In the "Acknowledgments" part, the Funding should be corrected as: Funding: The study was funded by specific grant from Istituto Auxologico Italiano. In the "Footnote" part, the Conflicts of Interest should be corrected as: Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://gs.amegroups.com/article/view/10.21037/gs-22-520/coif). The authors have no conflicts of interest to declare. In the ICMJE uniform disclosure form (available at https://gs.amegroups.com/article/view/10.21037/gs-22-520/coif), the funding information disclosed in item #1 should be corrected as: The study was funded by specific grant from Istituto Auxologico Italiano. The authors regret the error and all inconveniences caused. Click here to view the updated version of the article. Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

Erratum to : Introduction to the peripheral T-cell lymphoma review series: advances in molecular characterization, classification refinement and treatment optimization

Erratum to: DUSP22 -rearranged ALK-negative anaplastic large cell lymphoma is a pathogenetically distinct disease but can have variable clinical outcome

Erratum: Hepatic Carcinoma with Indolent T-lymphoblastic Proliferation (It-Lbp).

Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Erratum: Sun C, Tian X, Lee YS, et al. Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib. Blood. 2015;126(19):2213-2219

Erratum: Approaching hemophagocytic lymphohistiocytosis

Erratum: Thadi A.; et al. Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis. Vaccines 2018, 6, 54

Erratum: Palumbo A, Bringhen S, Mateos M-V, et al. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. Blood. 2015;125(13):2068-2074

Erratum: Schwartz CL, Constine LS, Villaluna D, et al. A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425. Blood. 2009;114(10):2051-2059

Erratum to: Soluble B-cell maturation antigen in lacrimal fluid as a potential biomarker and mediator of keratopathy in multiple myeloma

Erratum to Erratum to relationships between serum levels of vitamins and papillary thyroid cancer: a single center case-control study

Correction Notice: Impact of T-cell Receptor Status on Mutational Landscape and Outcome in T-ALL

Erratum: Development of Auer bodies from giant inclusions associated with rough endoplasmic reticulum in acute promyelocytic leukemia

ERRATUM: Mutational landscape of non-functional adrenocortical adenomas

Erratum: Evaluation of the clinicopathologic features of diffuse large B cell lymphoma after CD19-targeted CAR T-cell therapy emphasizing the potential diagnostic pitfalls.

Real-world data combined with studies on Regulatory B Cells for newly diagnosed Multiple Myeloma from a tertiary referral Hospital in South-Western China: Erratum

Erratum: Kini Bailur J, Mehta S, Zhang L, et al. Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapy. Blood Adv. 2017;1(25):2343-2347

Erratum: Preoperative immunological plasma markers TRAIL, CSF1, and TIE2 predict survival after resection for biliary tract cancer

Erratum: Genetic Predisposition to Numerous Large Ulcerating Basal Cell Carcinomas and Response to Immune Therapy: Erratum

Corrigendum: Follicular lymphoma regulatory T-cell origin and function

Erratum: Jayappa KD, Portell CA, Gordon VL, et al. Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL. Blood Adv. 2017;1(14):933-946